Trader Recordati SPA - RECm CFD
Ajouter aux favoris- Résumé
- Données historiques
- Événements
- Compte de résultat
- Bilan
- Flux de trésorerie
- Capital
Écart | 0.15 | ||||||||
Frais de position longue en overnight
Long position overnight fee
Aller vers la plateforme | -0.024161% | ||||||||
Frais de position courte en overnight
Short position overnight fee
Aller vers la plateforme | -0.020283% | ||||||||
Durée des frais en overnight | 22:00 (UTC) | ||||||||
Quantité minimale négociée | 1 | ||||||||
Devise | EUR | ||||||||
Marge | 20% | ||||||||
Bourse | Italy | ||||||||
Commission sur la négociation | 0% |
*Information provided by Capital.com
Recordati Industria Chimica e Farmaceutica SpA ESG Risk Ratings
‘B’ score indicates good relative ESG performance and above average degree of transparency in reporting material ESG data publicly.
Fermeture précédente* | 40.45 |
Ouvert* | 40.46 |
Variation sur 1 an* | -14.53% |
Fourchette du jour* | 40.39 - 41.02 |
Fourchette sur 52 semaines | 34.52-49.83 |
Volume moyen (10 jours) | 195.74K |
Volume moyen (3 mois) | 4.41M |
Capitalisation boursière | 8.49B |
Ratio C/B | 25.54 |
Actions en circulation | 205.46M |
Revenu | 1.80B |
EPS | 1.59 |
Dividende (rendement en %) | 2.75726 |
Bêta | 0.18 |
Prochaine date de publication des résultats | Feb 21, 2023 |
Toutes les données sont fournies par Refinitiv, à l'exception des données marquées d'un astérisque, qui sont des *données fournies par Capital.com
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
Date | Clôture | Change | Change (%) | Ouverture | High | Low |
---|---|---|---|---|---|---|
Feb 6, 2023 | 40.45 | 0.64 | 1.61% | 39.81 | 40.51 | 39.43 |
Feb 3, 2023 | 40.13 | 0.45 | 1.13% | 39.68 | 40.34 | 39.41 |
Feb 2, 2023 | 39.95 | 0.59 | 1.50% | 39.36 | 40.23 | 39.25 |
Feb 1, 2023 | 39.13 | -0.96 | -2.39% | 40.09 | 40.22 | 38.87 |
Jan 31, 2023 | 39.99 | -0.98 | -2.39% | 40.97 | 41.00 | 39.94 |
Jan 30, 2023 | 41.24 | 0.87 | 2.16% | 40.37 | 41.30 | 40.32 |
Jan 27, 2023 | 40.65 | 0.34 | 0.84% | 40.31 | 40.67 | 39.95 |
Jan 26, 2023 | 40.54 | -0.66 | -1.60% | 41.20 | 41.43 | 40.45 |
Jan 25, 2023 | 40.84 | -0.24 | -0.58% | 41.08 | 41.11 | 40.34 |
Jan 24, 2023 | 41.30 | -0.17 | -0.41% | 41.47 | 41.61 | 41.06 |
Jan 23, 2023 | 41.32 | -0.40 | -0.96% | 41.72 | 41.75 | 40.87 |
Jan 20, 2023 | 41.62 | 0.01 | 0.02% | 41.61 | 42.13 | 41.50 |
Jan 19, 2023 | 41.64 | -0.40 | -0.95% | 42.04 | 42.32 | 41.54 |
Jan 18, 2023 | 42.01 | 0.35 | 0.84% | 41.66 | 42.31 | 41.44 |
Jan 17, 2023 | 41.83 | 1.40 | 3.46% | 40.43 | 41.96 | 39.95 |
Jan 16, 2023 | 40.03 | -0.12 | -0.30% | 40.15 | 40.31 | 39.92 |
Jan 13, 2023 | 40.05 | 0.66 | 1.68% | 39.39 | 40.26 | 39.35 |
Jan 12, 2023 | 39.19 | 0.53 | 1.37% | 38.66 | 39.23 | 38.59 |
Jan 11, 2023 | 38.78 | -0.21 | -0.54% | 38.99 | 39.20 | 38.75 |
Jan 10, 2023 | 39.01 | 0.20 | 0.52% | 38.81 | 39.27 | 38.77 |
Recordati SPA Events
Time (UTC) | Country | Event |
---|---|---|
No events scheduled |
- Annuel
- Trimestriel
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | |
---|---|---|---|---|---|---|
Revenu total | 1153.94 | 1288.12 | 1352.23 | 1481.85 | 1448.87 | 1580.07 |
Revenu | 1153.94 | 1288.12 | 1352.23 | 1481.85 | 1448.87 | 1580.07 |
Coût des recettes, total | 360.959 | 382.754 | 395.569 | 436.901 | 406.831 | 427.727 |
Résultat brut | 792.983 | 905.369 | 956.666 | 1044.95 | 1042.04 | 1152.35 |
Total des frais d'exploitation | 826.519 | 881.631 | 910.016 | 1016.58 | 979.851 | 1089.88 |
Total des frais de vente/Généraux/Admin | 369.219 | 396.375 | 401.219 | 445.586 | 421.857 | 480.889 |
Recherche et développement | 83.71 | 100.256 | 67.093 | 77.081 | 146.236 | 166.138 |
Charges (revenus) inhabituelles | 12.631 | 2.246 | 3.535 | 0.264 | 4.927 | 14.478 |
Produits d'exploitation | 327.423 | 406.492 | 442.219 | 465.266 | 469.016 | 490.19 |
Produits (charges) d'intérêts, nets Hors exploitation | -9.866 | -17.148 | -17.977 | -20.616 | -13.203 | -26.718 |
Autres, nets | -0.275 | -0.229 | -6.307 | -0.506 | -0.157 | -0.123 |
Résultat net avant impôts | 317.282 | 389.115 | 417.935 | 444.144 | 455.656 | 463.349 |
Résultat net après impôts | 237.431 | 288.799 | 312.422 | 368.866 | 355.027 | 385.966 |
Intérêts minoritaires | -0.025 | -0.037 | -0.046 | -0.041 | -0.043 | 0 |
Résultat net avant éléments extra | 237.406 | 288.762 | 312.376 | 368.825 | 354.984 | 385.966 |
Résultat net | 237.406 | 288.762 | 312.376 | 368.825 | 354.984 | 385.966 |
Revenu disponible pour les actionnaires ordinaires, hors éléments exceptionnels | 237.406 | 288.762 | 312.376 | 368.825 | 354.984 | 385.966 |
Bénéfice disponible pour les actionnaires ordinaires, y compris les éléments exceptionnels | 237.406 | 288.762 | 312.376 | 368.825 | 354.984 | 385.966 |
Ajustement pour dilution | 0.025 | |||||
Résultat net dilué | 237.431 | 288.762 | 312.376 | 368.825 | 354.984 | 385.966 |
Moyenne pondérée des actions diluées | 209.19 | 209.096 | 209.087 | 209.084 | 209.06 | 209.082 |
BPA dilué hors éléments extraordinaires | 1.135 | 1.381 | 1.494 | 1.764 | 1.698 | 1.846 |
Dividends per Share - Common Stock Primary Issue | 0.7 | 0.85 | 0.92 | 1 | 1.05 | 1.1 |
BPA dilué normalisé | 1.18018 | 1.38897 | 1.50664 | 1.76505 | 1.7131 | 1.89642 |
Depreciation / Amortization | 42.6 | 52.6 | ||||
Other Operating Expenses, Total | 4.15 | 0 | 0.652 |
Q1 2021 | Q2 2021 | Q3 2021 | Q4 2021 | Q1 2022 | |
---|---|---|---|---|---|
Revenu total | 384.838 | 385.997 | 385.354 | 423.885 | 419.381 |
Revenu | 384.838 | 385.997 | 385.354 | 423.885 | 419.381 |
Coût des recettes, total | 104.069 | 101.871 | 107.065 | 114.722 | 115.478 |
Résultat brut | 280.769 | 284.126 | 278.289 | 309.163 | 303.903 |
Total des frais d'exploitation | 259.951 | 260.516 | 262.795 | 306.622 | 288.11 |
Total des frais de vente/Généraux/Admin | 113.409 | 117.419 | 116.236 | 133.825 | 121.733 |
Recherche et développement | 41.456 | 39.673 | 38.562 | 46.447 | 43.669 |
Charges (revenus) inhabituelles | 0.774 | 0.561 | 0.487 | 12.656 | 7.115 |
Other Operating Expenses, Total | 0.243 | 0.992 | 0.445 | -1.028 | 0.115 |
Produits d'exploitation | 124.887 | 125.481 | 122.559 | 117.263 | 131.271 |
Produits (charges) d'intérêts, nets Hors exploitation | -8.883 | -5.964 | -7.313 | -4.558 | -6.926 |
Autres, nets | -0.01 | -0.011 | -0.01 | -0.092 | -0.027 |
Résultat net avant impôts | 115.994 | 119.506 | 115.236 | 112.613 | 124.318 |
Résultat net après impôts | 89.884 | 117.222 | 89.28 | 89.58 | 96.72 |
Intérêts minoritaires | -0.012 | -0.01 | 0.022 | 0 | |
Résultat net avant éléments extra | 89.872 | 117.212 | 89.302 | 89.58 | 96.72 |
Résultat net | 89.872 | 117.212 | 89.302 | 89.58 | 96.72 |
Revenu disponible pour les actionnaires ordinaires, hors éléments exceptionnels | 89.872 | 117.212 | 89.302 | 89.58 | 96.72 |
Bénéfice disponible pour les actionnaires ordinaires, y compris les éléments exceptionnels | 89.872 | 117.212 | 89.302 | 89.58 | 96.72 |
Résultat net dilué | 89.872 | 117.212 | 89.302 | 89.58 | 96.72 |
Moyenne pondérée des actions diluées | 209.005 | 209.347 | 209.142 | 208.836 | 209.351 |
BPA dilué hors éléments extraordinaires | 0.43 | 0.55989 | 0.42699 | 0.42895 | 0.462 |
Dividends per Share - Common Stock Primary Issue | 0 | 0.53 | 0 | 0.57 | 0 |
BPA dilué normalisé | 0.43 | 0.55874 | 0.42699 | 0.48058 | 0.48849 |
- Annuel
- Trimestriel
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | |
---|---|---|---|---|---|---|
Total de l'actif à court terme | 552.233 | 773.685 | 699.931 | 809.35 | 772.951 | 850.101 |
Espèces et placements à court terme | 138.493 | 302.077 | 198.036 | 187.923 | 188.23 | 244.578 |
Cash | 117.17 | 273.343 | 172.421 | 141.384 | 175.227 | 230.924 |
Trésorerie et équivalents | 21.323 | 28.734 | 25.615 | 46.539 | 13.003 | 13.654 |
Total des créances, nettes | 228.9 | 282.478 | 281.276 | 374.328 | 313.859 | 350.335 |
Accounts Receivable - Trade, Net | 205.988 | 244.117 | 245.742 | 296.961 | 268.897 | 307.778 |
Total Inventory | 158.8 | 179.1 | 206.084 | 226.885 | 251.252 | 228.732 |
Prepaid Expenses | 8.062 | 6.205 | 8.121 | 10.265 | 12.574 | 15.307 |
Other Current Assets, Total | 17.978 | 3.825 | 6.414 | 9.949 | 7.036 | 11.149 |
Total Assets | 1560.74 | 2056.41 | 2161.26 | 2808.93 | 2711.65 | 2816.2 |
Property/Plant/Equipment, Total - Net | 110.202 | 103.009 | 103.582 | 133.342 | 133.25 | 131.12 |
Property/Plant/Equipment, Total - Gross | 374.684 | 376.699 | 387.858 | 437.716 | 453.036 | 462.825 |
Accumulated Depreciation, Total | -264.482 | -273.69 | -284.276 | -304.374 | -319.786 | -331.705 |
Goodwill, Net | 556.566 | 539.871 | 577.786 | 577.973 | 562.116 | 553.209 |
Intangibles, Net | 279.884 | 540.565 | 672.106 | 1161.76 | 1115.81 | 1138.79 |
Long Term Investments | 19.199 | 24.171 | 20.773 | 38.566 | 45.581 | 34.124 |
Other Long Term Assets, Total | 42.659 | 75.106 | 87.087 | 87.939 | 81.945 | 108.859 |
Total Current Liabilities | 311.31 | 375.546 | 490.742 | 586.754 | 578.464 | 626.416 |
Accounts Payable | 124.644 | 141.74 | 165.02 | 175.481 | 132.096 | 177.925 |
Accrued Expenses | 42.807 | 43.68 | 42.289 | 45.267 | 39.649 | 56.191 |
Notes Payable/Short Term Debt | 15.689 | 16.577 | 16.905 | 13.392 | 12.567 | 8.657 |
Current Port. of LT Debt/Capital Leases | 40.428 | 51.71 | 130.583 | 149.817 | 270.254 | 223.061 |
Other Current Liabilities, Total | 87.742 | 121.839 | 135.945 | 202.797 | 123.898 | 160.582 |
Total Liabilities | 656.913 | 1029.32 | 1197.87 | 1610.35 | 1435.67 | 1434.57 |
Total Long Term Debt | 293.644 | 612.462 | 640.647 | 937.344 | 778.238 | 760.473 |
Long Term Debt | 293.644 | 612.462 | 640.647 | 937.344 | 760.587 | 745.382 |
Deferred Income Tax | 27.659 | 17.554 | 43.486 | 43.172 | 41.219 | 26.675 |
Minority Interest | 0.11 | 0.147 | 0.193 | 0.234 | 0.277 | 0 |
Other Liabilities, Total | 24.19 | 23.608 | 22.804 | 42.849 | 37.473 | 21.01 |
Total Equity | 903.83 | 1027.09 | 963.393 | 1198.58 | 1275.98 | 1381.62 |
Common Stock | 26.141 | 26.141 | 26.141 | 26.141 | 26.141 | 26.141 |
Additional Paid-In Capital | 83.719 | 83.719 | 83.719 | 83.719 | 83.719 | 83.719 |
Retained Earnings (Accumulated Deficit) | 956.46 | 1064.13 | 1161.69 | 1334.42 | 1473.6 | 1612.81 |
Treasury Stock - Common | -76.761 | -17.029 | -145.608 | -93.48 | -87.516 | -126.981 |
Other Equity, Total | -85.729 | -129.871 | -162.545 | -152.223 | -219.962 | -214.06 |
Total Liabilities & Shareholders’ Equity | 1560.74 | 2056.41 | 2161.26 | 2808.93 | 2711.65 | 2816.2 |
Total Common Shares Outstanding | 205.234 | 208.262 | 204.379 | 204.959 | 206.296 | 205.911 |
Capital Lease Obligations | 17.651 | 15.091 |
Mar 2021 | Jun 2021 | Sep 2021 | Dec 2021 | Mar 2022 | |
---|---|---|---|---|---|
Total de l'actif à court terme | 861.321 | 907.382 | 958.115 | 850.101 | 961.621 |
Espèces et placements à court terme | 250.085 | 271.869 | 341.926 | 244.578 | 261.43 |
Trésorerie et équivalents | 250.085 | 271.869 | 341.926 | 244.578 | 261.43 |
Total des créances, nettes | 343.118 | 357.259 | 345.649 | 352.658 | 407.68 |
Accounts Receivable - Trade, Net | 307.91 | 304.542 | 300.769 | 307.778 | 367.012 |
Total Inventory | 243.684 | 257 | 244.501 | 228.732 | 256.489 |
Other Current Assets, Total | 24.434 | 9.067 | 26.039 | 11.149 | 36.022 |
Total Assets | 2837.47 | 2875.92 | 2929.54 | 2816.2 | 3642.95 |
Property/Plant/Equipment, Total - Net | 131.384 | 130.9 | 132.992 | 131.12 | 129.207 |
Property/Plant/Equipment, Total - Gross | 455.542 | 458.108 | 464.546 | 462.825 | 464.469 |
Accumulated Depreciation, Total | -324.158 | -327.208 | -331.554 | -331.705 | -335.262 |
Goodwill, Net | 560.466 | 559.899 | 560.309 | 553.209 | 1125.12 |
Intangibles, Net | 1143.84 | 1132.93 | 1128.04 | 1138.79 | 1292.75 |
Long Term Investments | 47.405 | 39.672 | 41.963 | 34.124 | 23.34 |
Other Long Term Assets, Total | 93.055 | 105.135 | 108.13 | 108.859 | 110.922 |
Total Current Liabilities | 628.61 | 586.368 | 610.638 | 626.416 | 725.019 |
Accounts Payable | 145.065 | 160.355 | 166.917 | 177.925 | 194.998 |
Notes Payable/Short Term Debt | 35.997 | 29.106 | 13.478 | 8.657 | 15.022 |
Current Port. of LT Debt/Capital Leases | 275.06 | 222.805 | 228.168 | 223.061 | 252.279 |
Other Current Liabilities, Total | 172.488 | 174.102 | 202.075 | 216.773 | 262.72 |
Total Liabilities | 1508.69 | 1547.83 | 1484.48 | 1434.57 | 2193.52 |
Total Long Term Debt | 800.325 | 895.648 | 824.701 | 760.473 | 1403.58 |
Long Term Debt | 800.325 | 879.552 | 808.965 | 745.382 | 1389.77 |
Deferred Income Tax | 41.11 | 27.17 | 27.787 | 26.675 | 26.909 |
Minority Interest | 0.289 | 0.299 | 0 | 0 | 0 |
Other Liabilities, Total | 38.354 | 38.343 | 21.351 | 21.01 | 38.015 |
Total Equity | 1328.78 | 1328.09 | 1445.07 | 1381.62 | 1449.43 |
Common Stock | 26.141 | 26.141 | 26.141 | 26.141 | 26.141 |
Additional Paid-In Capital | 83.719 | 83.719 | 83.719 | 83.719 | 83.719 |
Retained Earnings (Accumulated Deficit) | 1562.21 | 1552.6 | 1640.89 | 1612.81 | 1699.78 |
Treasury Stock - Common | -126.637 | -115.257 | -98.924 | -126.981 | -144.381 |
Other Equity, Total | -216.649 | -219.116 | -206.753 | -214.06 | -215.826 |
Total Liabilities & Shareholders’ Equity | 2837.47 | 2875.92 | 2929.54 | 2816.2 | 3642.95 |
Total Common Shares Outstanding | 205.479 | 205.909 | 206.365 | 205.911 | 205.587 |
Prepaid Expenses | 12.187 | 12.984 | |||
Capital Lease Obligations | 16.096 | 15.736 | 15.091 | 13.81 |
- Annuel
- Trimestriel
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | |
---|---|---|---|---|---|---|
Revenu net/Ligne de départ | 237.431 | 288.799 | 312.422 | 368.866 | 355.027 | 385.966 |
Liquidités provenant des activités d'exploitation | 255.436 | 272.711 | 357.838 | 318.7 | 403.575 | 492.129 |
Liquidités provenant des activités d'exploitation | 12.466 | 14.186 | 13.901 | 25.17 | 25.355 | 25.294 |
Amortization | 25.466 | 33.967 | 42.959 | 53.078 | 68.317 | 72.291 |
Deferred Taxes | -5.637 | -32.422 | -6.637 | |||
Éléments non monétaires | 6.919 | -11.407 | 4.697 | 102.747 | 124.979 | 113.194 |
Variation du fonds de roulement | -21.209 | -20.412 | -9.504 | -231.161 | -170.103 | -104.616 |
Flux de trésorerie liés aux activités d'investissement | -158.489 | -321.188 | -231.778 | -441.209 | -131.555 | -87.499 |
Dépenses d'investissement | -19.669 | -14.588 | -19.362 | -443.288 | -131.678 | -87.36 |
Autres éléments de flux de trésorerie d'investissement, total | -138.82 | -306.6 | -212.416 | 2.079 | 0.123 | -0.139 |
Flux de trésorerie provenant des activités de financement | -189.819 | 224.656 | -224.688 | 109.526 | -264.288 | -355.943 |
Éléments de flux de trésorerie de financement | -1.679 | 3.716 | 0.439 | -2.19 | 1.74 | |
Total Cash Dividends Paid | -133.73 | -159.607 | -178.887 | -190.916 | -212.718 | -216.742 |
Émission (remboursement) d'actions, nette | -48.886 | 30.267 | -149.552 | 26.187 | -12.17 | -59.308 |
Émission (remboursement) de la dette, nette | -5.524 | 350.28 | 103.312 | 276.445 | -41.14 | -79.893 |
Variation nette de la trésorerie | -92.872 | 162.696 | -104.369 | -10.113 | 0.307 | 56.348 |
Effets de change | -13.483 | -5.741 | 2.87 | -7.425 | 7.661 | |
Cash Taxes Paid | 140.14 | 65.272 | 91.646 | |||
Intérêts payés en espèces | 17.597 | 18.699 | 18.279 |
Mar 2021 | Jun 2021 | Sep 2021 | Dec 2021 | Mar 2022 | |
---|---|---|---|---|---|
Net income/Starting Line | 89.884 | 207.106 | 296.386 | 385.966 | 96.72 |
Cash From Operating Activities | 114.135 | 213.826 | 368.622 | 492.129 | 113.431 |
Cash From Operating Activities | 6.311 | 12.633 | 18.928 | 25.294 | 6.016 |
Amortization | 18.049 | 35.873 | 53.968 | 72.291 | 18.635 |
Non-Cash Items | 31.74 | 40.95 | 73.508 | 113.194 | 35.714 |
Cash Taxes Paid | 6.302 | 46.563 | 61.599 | 91.646 | 10.653 |
Cash Interest Paid | 2.243 | 9.147 | 11.476 | 18.279 | 2.344 |
Changes in Working Capital | -31.849 | -82.736 | -74.168 | -104.616 | -43.654 |
Cash From Investing Activities | -57.132 | -66.56 | -76.89 | -87.499 | -722.27 |
Capital Expenditures | -57.317 | -66.718 | -76.744 | -87.36 | -15.599 |
Other Investing Cash Flow Items, Total | 0.185 | 0.158 | -0.146 | -0.139 | -706.671 |
Cash From Financing Activities | 1.754 | -66.585 | -143.698 | -355.943 | 571.438 |
Total Cash Dividends Paid | -0.74 | -108.699 | -109.389 | -216.742 | -6.219 |
Issuance (Retirement) of Stock, Net | -43.227 | -40.458 | -29.028 | -59.308 | -18.383 |
Issuance (Retirement) of Debt, Net | 45.721 | 82.572 | -5.281 | -79.893 | 596.04 |
Foreign Exchange Effects | 3.098 | 2.958 | 5.662 | 7.661 | 1.018 |
Net Change in Cash | 61.855 | 83.639 | 153.696 | 56.348 | -36.383 |
Nom de l'investisseur | Catégorie de l'investisseur | Pourcentage de l'encours | Actions détenues | Changement d'actions | Date d'avoirs | Taux du chiffre d'affaires |
---|---|---|---|---|---|---|
Fimei Finanziaria Industriale Mobiliare Ed Immobiliare SpA | Holding Company | 51.82 | 108368656 | 0 | 2023-01-04 | LOW |
Mawer Investment Management Ltd. | Investment Advisor | 4.997 | 10449984 | -43916 | 2022-12-07 | LOW |
Fidelity Management & Research Company LLC | Investment Advisor | 3.402 | 7114438 | 0 | 2023-01-04 | LOW |
FMR Investment Management (U.K.) Limited | Investment Advisor | 1.7855 | 3733978 | -13156 | 2022-12-31 | LOW |
The Vanguard Group, Inc. | Investment Advisor/Hedge Fund | 1.3647 | 2853934 | 21111 | 2022-12-31 | LOW |
BlackRock Institutional Trust Company, N.A. | Investment Advisor | 1.2698 | 2655430 | -21481 | 2023-01-31 | LOW |
Norges Bank Investment Management (NBIM) | Sovereign Wealth Fund | 0.968 | 2024252 | 293858 | 2022-12-31 | LOW |
La Financière de l'Echiquier | Investment Advisor | 0.618 | 1292377 | 40 | 2022-11-30 | MED |
Geode Capital Management, L.L.C. | Investment Advisor/Hedge Fund | 0.5221 | 1091897 | 5 | 2023-01-31 | LOW |
BlackRock Advisors (UK) Limited | Investment Advisor/Hedge Fund | 0.451 | 943207 | -6025 | 2022-12-31 | LOW |
Manulife Investment Management (North America) Limited | Investment Advisor | 0.4196 | 877523 | 17954 | 2022-11-30 | LOW |
Invesco Advisers, Inc. | Investment Advisor | 0.405 | 846946 | 66300 | 2022-12-31 | LOW |
California Public Employees' Retirement System | Pension Fund | 0.371 | 775787 | -99342 | 2021-06-30 | LOW |
Amundi Asset Management, SAS | Investment Advisor/Hedge Fund | 0.3659 | 765091 | 519 | 2022-12-31 | HIGH |
State Street Global Advisors (UK) Ltd. | Investment Advisor/Hedge Fund | 0.361 | 754985 | -23096 | 2022-12-31 | LOW |
TD Asset Management Inc. | Investment Advisor | 0.3407 | 712591 | 1039 | 2022-12-31 | LOW |
Epoch Investment Partners, Inc. | Investment Advisor | 0.331 | 692301 | -46 | 2022-12-31 | LOW |
Walter Scott & Partners Ltd. | Investment Advisor/Hedge Fund | 0.3308 | 691687 | -643 | 2022-12-31 | LOW |
Dimensional Fund Advisors, L.P. | Investment Advisor/Hedge Fund | 0.2699 | 564365 | 346 | 2023-01-31 | LOW |
Caisse de Depot et Placement du Quebec | Pension Fund | 0.2663 | 556837 | 450028 | 2021-12-31 | LOW |
Pourquoi choisir capital.com? Nos chiffres parlent d'eux-mêmes.
Capital.com GroupTradeurs
Clients actifs par mois
Volume d'investissement par mois
Retrait par mois
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 2:1
- 5:1
- 10:1
- 20:1
- 20
- 100
- 500
- 1000
- 10000
Recordati Company profile
À propos de Recordati Industria Chimica e Farma SpA
Recordati Industria Chimica e Farmaceutica SpA est un groupe basé en Italie spécialisé dans la recherche, le développement, la fabrication et la commercialisation de produits pharmaceutiques. Elle favorise un large éventail de produits pharmaceutiques, à la fois propriétaires et sous licence, dans un certain nombre de domaines thérapeutiques, tels que les antibiotiques et les antiviraux, les maladies cardiovasculaires, le système nerveux central, la dermatologie, la gastroentérologie, le système génital-urinaire, les troubles musculo-squelettiques et la douleur, Obstétrique et Gynécologie et sans ordonnance (OTC) pharmaceutiques. La Société est engagée dans la recherche et le développement de nouvelles entités pharmaceutiques dans les domaines thérapeutiques cardiovasculaires et urogénitaux et des traitements contre les maladies rares. Son produit est ZANIDIP, un bloqueur de canal de calcium de dernière génération pour le traitement de l'hypertension. Elle fonctionne à travers Italchimici SpA, Pro Farma AG et les droits de commercialisation nord-américains de Cystadane. La Société possède et exploite également Natural Point srl dans le secteur des compléments alimentaires.
- IndustriePharmaceuticals (NEC)
- AdresseVia M. Civitali, 1, MILANO, Italy (ITA)
- Employés4303
- CEOAndrea Recordati
Industry: | Pharmaceuticals (NEC) |
Via M. Civitali, 1
MILANO
MILANO 20148
IT
Compte de résultat
- Annual
- Quarterly
Les gens regardent aussi
Êtes-vous toujours à la recherche d'un broker de confiance?
Rejoignez les plus de 500 000 traders du monde entier qui ont choisi de trader avec Capital.com